Generics 1



Medical devices



Exenatide manufacturers

1 products found



Filters , active

Country of origin : Netherlands

Clear all

1 products found


Injection 2 mg

Dossier type
Dossier status
Under development
Country of origin
European Union
GMP approvals
Manufacturer #17457
In the past fifty years, the company has reached significant milestones—a result of enviable performance, strict adherence to the highest ethical and operational standards, and full compliance with global regulatory authorities. During this journey, they have emerged as one of the leading in-house development partners based in Europe, specializing in the development, registration, manufacturing, and life-cycle management of highly complex pharmaceutical technologies and generic formulations.

Manufacturer usually replies in 23 days

Exenatide is a medication that is used to treat type 2 diabetes. The supplier of exenatide markets it in the form of fast-release as well as extended-release injectable solution preparation kits as well as injectable solutions. The drug was first approved for medical use in 2005 and has since become registered and marketed in over 80 countries worldwide. Exenatide’s manufacturer is Amylin Pharmaceuticals, whereas the commercialization and distribution rights belong to Astra Zeneca (i.e. it is the sole exenatide supplier globally). Given that the supplier’s patent for exenatide is still valid, other manufacturers and vendors have yet to introduce generic or trade name formulations of the drug. The retail prices per 4 injectable solution kits with 2mg powder of exenatide and solvent for an extended-release injectable solution costs approximately 90,00 EUR to 120,00 EUR. Pharmaceutical specialists are welcome to browse through offers of exenatide injectable solution kits for sale from exenatide suppliers and distributors on our pharmaceutical marketplace, or else seek out further useful medical information about the medication online at the official Byetta website.